[ccpw id="5"]

Home.forex news reportWhat to Expect From McDonald's Next Quarterly Earnings Report

What to Expect From McDonald’s Next Quarterly Earnings Report

-


McDonald’s Corporation (MCD), headquartered in Chicago, Illinois, operates and franchises fast food chains under the McDonald’s brand. Valued at $218.5 billion by market cap, MCD is the world’s largest fast food restaurant chain that offers various food products and soft drinks, and non-alcoholic beverages. With a global presence in over 40,000 locations in more than 100 countries, approximately 95% of its restaurants are owned and operated by independent local business owners. The fast-food giant is expected to announce its fiscal fourth-quarter earnings for 2025 in the near term.

Ahead of the event, analysts expect MCD to report a profit of $3 per share on a diluted basis, up 6% from $2.83 per share in the year-ago quarter. The company beat or matched the consensus estimates in three of the last four quarters while missing the forecast on another occasion.

For the full year, analysts expect MCD to report EPS of $12.09, up 3.2% from $11.72 in fiscal 2024. Its EPS is expected to rise 9.9% year over year to $13.29 in fiscal 2026.

www.barchart.com
www.barchart.com

MCD stock has underperformed the S&P 500 Index’s ($SPX) 19.7% gains over the past 52 weeks, with shares up 8.7% during this period. Similarly, it underperformed the Consumer Discretionary Select Sector SPDR Fund’s (XLY) 12.8% gains over the same time frame.

www.barchart.com
www.barchart.com

On Nov. 5, 2025, MCD shares closed up more than 2% after reporting its Q3 results. Its adjusted EPS of $3.22 missed Wall Street expectations of $3.35. The company’s revenue was $7.08 billion, beating Wall Street forecasts of $7.07 billion.

Analysts’ consensus opinion on MCD stock is moderately bullish, with a “Moderate Buy” rating overall. Out of 35 analysts covering the stock, 16 advise a “Strong Buy” rating, one suggests a “Moderate Buy,” 17 give a “Hold,” and one recommends a “Strong Sell.” MCD’s average analyst price target is $338.64, indicating a potential upside of 10.4% from the current levels.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

It isn’t panic time yet – North American session Market wrap for January 14

Log in to today's North American session Market wrap for January 14Today's session unleashed a wave of panic across global markets, driven by a...

Here’s What to Expect From Vertex Pharmaceuticals’ Next Earnings Report

With a market cap of $116.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company focused on developing and commercializing innovative therapies,...

Mar Vista’s U.S. Quality Strategy Divested Its Stake in Equifax (EFX)

Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Strategy” fourth-quarter 2025 investor letter. A copy...

Heartland Value Fund Added Integer Holdings Corporation (ITGR) Following Its Stock Repurchase

Heartland Advisors, an investment management company, released its “Heartland Value Fund” fourth-quarter 2025 investor letter. A copy of the letter can...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img